StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Clene Inc.
NasdaqCM:CLNN
Sector
Location
Market Cap
USD 32.25 M
Share Price
USD 3.59
Avg Daily Volume
92,468
Change (1 day)
-4.52%
Change (1 year)
-29.33%
Change (YTD)
-32.39%
Clene Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2025: -8,450.29%
Clene Inc. EBIT Margin is -8,450.29% for the Trailing 12 Months (TTM) ending March 31, 2025. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
-
Clene Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -4,500.73%, a 8.54% change year over year.
-
Clene Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was -4,146.67%, a -74.43% change year over year.
-
Clene Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was -16,214.90%, a -32.52% change year over year.
Competitors
Chugai Pharmaceutical Co., Ltd.
USD 46.36
4519.T
-0.52
-1.11%
MERCK Kommanditgesellschaft auf Aktien
USD 131.84
MRK.DE
-2.06
-1.54%
Agilent Technologies, Inc.
USD 123.28
A
-0.89
-0.72%
Qiagen N.V.
USD 48.13
QGEN
-0.42
-0.86%
Aurobindo Pharma Limited
USD 13.09
AUROPHARMA.NS
-0.09
-0.66%
Repligen Corporation
USD 130.19
RGEN
-3.81
-2.84%
Bruker Corporation
USD 43.79
BRKR
+0.21
0.48%
Pharmaron Beijing Co., Ltd.
USD 2.37
3759.HK
+0.22
10.05%
Yuhan Corporation
USD 80.76
000100.KS
-0.51
-0.63%
Bachem Holding AG
USD 72.11
BANB.SW
-0.51
-0.71%
Siegfried Holding AG
USD 112.96
SFZN.SW
+0.27
0.24%
Gan & Lee Pharmaceuticals.
USD 7.79
603087.SS
+0.05
0.71%
Cohance Lifesciences Limited
USD 11.85
COHANCE.NS
+0.23
2.00%
Metsera, Inc.
USD 39.28
MTSR
+2.87
7.88%
Bloomage BioTechnology Corporation Limited
USD 7.17
688363.SS
-0.01
-0.14%
Syngene International Limited
USD 7.29
SYNGENE.NS
-0.11
-1.49%
Jafron Biomedical Co.,Ltd.
USD 3.15
300529.SZ
+0.01
0.21%
Beijing Hotgen Biotech Co., Ltd.
USD 26.08
688068.SS
-0.38
-1.45%
Anbio Biotechnology Class A Ordinary Shares
USD 49.26
NNNN
-1.48
-2.92%
Anhui Anke Biotechnology (Group) Co., Ltd.
USD 1.26
300009.SZ
-0.01
-1.13%
Key Data
| Date | EBIT Margin | EBITDA Margin | Net Income Margin | EBT Margin |
|---|
Competitors
Chugai Pharmaceutical Co., Ltd.
USD 46.36
4519.T
-0.52
-1.11%
MERCK Kommanditgesellschaft auf Aktien
USD 131.84
MRK.DE
-2.06
-1.54%
Agilent Technologies, Inc.
USD 123.28
A
-0.89
-0.72%
Qiagen N.V.
USD 48.13
QGEN
-0.42
-0.86%
Aurobindo Pharma Limited
USD 13.09
AUROPHARMA.NS
-0.09
-0.66%
Repligen Corporation
USD 130.19
RGEN
-3.81
-2.84%
Bruker Corporation
USD 43.79
BRKR
+0.21
0.48%
Pharmaron Beijing Co., Ltd.
USD 2.37
3759.HK
+0.22
10.05%
Yuhan Corporation
USD 80.76
000100.KS
-0.51
-0.63%
Bachem Holding AG
USD 72.11
BANB.SW
-0.51
-0.71%
Siegfried Holding AG
USD 112.96
SFZN.SW
+0.27
0.24%
Gan & Lee Pharmaceuticals.
USD 7.79
603087.SS
+0.05
0.71%
Cohance Lifesciences Limited
USD 11.85
COHANCE.NS
+0.23
2.00%
Metsera, Inc.
USD 39.28
MTSR
+2.87
7.88%
Bloomage BioTechnology Corporation Limited
USD 7.17
688363.SS
-0.01
-0.14%
Syngene International Limited
USD 7.29
SYNGENE.NS
-0.11
-1.49%
Jafron Biomedical Co.,Ltd.
USD 3.15
300529.SZ
+0.01
0.21%
Beijing Hotgen Biotech Co., Ltd.
USD 26.08
688068.SS
-0.38
-1.45%
Anbio Biotechnology Class A Ordinary Shares
USD 49.26
NNNN
-1.48
-2.92%
Anhui Anke Biotechnology (Group) Co., Ltd.
USD 1.26
300009.SZ
-0.01
-1.13%